Intermediate term results for iodine 125 brachytherapy for favourable risk prostate cancer for 556 patients

被引：0
|
作者：
Crook, J. [1 ]
Yeung, I. [1 ]
Gillan, C. [1 ]
McLean, M. [1 ]
Lockwood, G. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80883-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [41] Outcome of young patients treated with 125I-brachytherapy for low and intermediate risk prostate carcinoma
    Kindts, I.
    Stellamans, K.
    Pottel, H.
    Lambrecht, A.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S156 - S156
  • [42] Sexual function following iodine 125 prostate brachytherapy
    Crook, J.
    Webster, D.
    Virtue, D.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S41 - S41
  • [43] Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
    Valeriani, Maurizio
    Di Staso, Mario
    Facondo, Giuseppe
    Vullo, Gianluca
    De Sanctis, Vitaliana
    Gravina, Giovanni Luca
    di Genesio Pagliuca, Milena
    Osti, Mattia Falchetto
    Bonfili, Pierluigi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [44] Long-term urinary sequelae following 125iodine prostate brachytherapy
    Crook, Juanita
    Fleshner, Neil
    Roberts, Chris
    Pond, Greg
    JOURNAL OF UROLOGY, 2008, 179 (01): : 141 - 145
  • [45] Is Iodine allergy a contraindication to prostate brachytherapy using Iodine125?
    Conterato, D.
    Braccioforte, M.
    Moran, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 242 - 242
  • [46] Extracranial stereotactic radiotherapy in low and favourable intermediate risk prostate cancer
    Navarro Aznar, V.
    Mendez Villamon, A.
    Puertas Valino, M. D. M.
    Garcia Aguilera, C.
    Cerrolaza Pascual, M.
    Lanuza Pascual, A.
    Ponce Ortega, J. M.
    Colom, C.
    Garcia Gimeno, B.
    Tejedor Gutierrez, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1217 - S1218
  • [47] PSA PROFILE OF CURED PATIENTS AFTER IODINE-125 PROSTATE BRACHYTHERAPY
    Crook, J.
    Gomez, A.
    Ma, C.
    McLean, M.
    Fung, S.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S7 - S8
  • [48] PATHOLOGICAL OUTCOMES IN FAVOURABLE VERSUS UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER
    Napodano, Giorgio
    Realfonso, Tommaso
    Campitelli, Antonio
    Intilla, Olivier
    Molisso, Giovanni
    Addesso, Maria
    Baio, Raffaele
    Sanseverino, Roberto
    ANTICANCER RESEARCH, 2019, 39 (03) : 1539 - 1541
  • [49] Ultrahypofractionated radiotherapy in low and favourable intermediate risk localised prostate cancer
    Colom Pla, Claudia
    Navarro Aznar, Victoria
    Garcia Aguilera, Cristina
    Cerrolaza Pascual, Maria
    Lanuza Carnicer, Alberto
    Galan Garcia, Ana
    Mendez Villamon, Agustina
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2530 - S2531
  • [50] Determinants of disease control following iodine-125 permanent seed brachytherapy in low risk prostate cancer
    Morton, G
    Loblaw, DA
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S38 - S39
12345